8-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF

THE SECURITIES EXCHANGE ACT OF 1934

Date of Report (date of earliest event reported): February 2, 2004

ENPATH MEDICAL, INC.

(Exact name of Registrant as specified in its charter)

Minnesota	0-19467		41-1533300
(State or other jurisdiction of incorporation)	(Commission File Number)		(I.R.S. Employer Identification No.)
15301 Highway 55 West Plymouth, MN		55447
(Address of principal executive offices)		(Zip Code)
Registrant’s telephone number, including area code:  (763) 559-2613
Former Name of Registrant:  Medamicus, Inc.

Items 1-4, 6, and 8-12 are not applicable and therefore omitted.

ITEM 5. OTHER EVENTS.

Effective February 2, 2004, Medamicus, Inc. changed its name to Enpath Medical, Inc. (the “Company”).  No other changes were made to the Company’s structure and it continues with the same rights and obligations as the former Medamicus, Inc.  The Company is listed on The Nasdaq Stock Market under the ticker symbol “NPTH.”

The Articles of Merger effecting the name change are attached as Exhibit 3.1 to this Current Report on Form 8-K.  A copy of the press release issued by the Company announcing the name change is attached as Exhibit 99.1 to this Form 8-K.

ITEM 7. FINANCIAL STATEMENTS AND EXHIBITS.

(c)Exhibits

The following are filed or furnished as Exhibits to this Report:

Exhibit No.	Description of Exhibit
3.1	Articles of Merger dated January 20, 2004.
99.1	Press release dated February 2, 2004, announcing change of the Company’s name from Medamicus, Inc. to Enpath Medical, Inc.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	MEDAMICUS, INC.
Dated:  February 2, 2004	By:	/s/ James D. Hartman
		James D. Hartman
		Chief Executive Officer

2

EX-3.1

Exhibit 3.1

MEDAMICUS, INC.

ARTICLES OF MERGER

Pursuant to Section 302A.621 of the Minnesota Business Corporation Act, the undersigned officer of Medamicus, Inc., a Minnesota corporation (the “Surviving Corporation”), which is the owner of all of the issued and outstanding shares of common stock, $.01 par value per share, of Enpath Medical, Inc., a Minnesota corporation (the “Subsidiary Corporation”), which is the only outstanding class of capital stock of the Subsidiary Corporation, hereby executes and files these Articles of Merger:

FIRST:The Plan of Merger providing for the merger of the Subsidiary Corporation into the Surviving Corporation, in the form of resolutions duly adopted by the Board of Directors of the Surviving Corporation on January 12, 2004, is attached hereto as Exhibit A.

SECOND:The number of outstanding shares of each class and series of the Subsidiary Corporation and the number of shares of each class and series of the Subsidiary Corporation owned by the Surviving Corporation are as follows:

Designation of Class & Series	Number of Outstanding Shares	Number of Shares Owned by Surviving Corporation
Common Stock, $.01 par value	1,000	1,000

THIRD:The Plan of Merger has been duly approved by the Surviving Corporation under Minnesota Statutes Section 302A.621.

FOURTH:There are no shareholders of the Subsidiary Corporation other than the Surviving Corporation, and accordingly, there is no notice required to any other shareholder pursuant to Minnesota Statutes Section 302A.621, subd. 2.

FIFTH:Upon the effective time of the merger, pursuant to Minnesota Statutes Section 302A.621, subd. 1, Article I of the Surviving Corporation’s Restated Articles of Incorporation shall be amended in its entirety to read as follows:

“The name of this Corporation is Enpath Medical, Inc.”

SIXTH:The merger is effective at 12:01 a.m., Central Time, on February 2, 2004.

Dated: January 20, 2004
	MEDAMICUS, INC.
	By:	/s/ James D. Hartman
			James D. Hartman, Chief Executive Officer

EXHIBIT A

PLAN OF MERGER

RESOLUTIONS OF THE BOARD OF DIRECTORS OF
MEDAMICUS, INC.

WHEREAS, the Company desires to effect the merger of the Subsidiary with and into the Company pursuant to Section 302A.621 of the Minnesota Business Corporation Act.

NOW, THEREFORE, BE IT RESOLVED, that the Subsidiary be merged with and into the Company pursuant to Section 302A.621 of the Minnesota Business Corporation Act in accordance with the further resolutions set forth below, which resolutions constitute the Plan of Merger.

FURTHER RESOLVED, that at the effective time of the merger, all of the outstanding shares of common stock of the Subsidiary, $.01 par value per share, will be canceled, and no securities of the Company or any other corporation, or any money or other property, will be issued to the Company in exchange therefore.

FURTHER RESOLVED, that James D. Hartman, Chief Executive Officer of the Company, is hereby authorized and directed to execute, for and on behalf of the Company, Articles of Merger setting forth the Plan of Merger and such other information as required by law, and to cause those articles to be filed with the Secretary of State of the State of Minnesota in the manner required by law.

FURTHER RESOLVED, that upon the effective time of the merger, pursuant to Section 302A.621, subd. 1, of the Minnesota Business Corporation Act, by virtue of filing of the Articles of Merger and without any further action by the Company, its Board of Directors, or its shareholders, Article I of the Company’s Restated Articles of Incorporation is amended in its entirety to read as follows:

“The name of this Corporation is Enpath Medical, Inc.”

FURTHER RESOLVED, that the officers of the Company, and each of them, are hereby authorized, for and on behalf of the Company, to take such other actions as those officers, or any of them, deem necessary or appropriate to carry out the purpose of the foregoing resolutions.

FURTHER RESOLVED, that this written action may be executed in any number of counterparts, each of which when so executed will be deemed an original and which together constitute one and the same instrument.

STATE OF MINNESOTA

DEPARTMENT OF STATE

FILED

JAN 20 2004

/s/ Mary Kiffmeyer

Secretary of State

EX-99.1

Exhibit 99.1

FOR IMMEDIATE RELEASE	Contact:	Jim Hartman
		Enpath Medical, Inc.
		(763) 577-2212
		EVC Group
		Douglas Sherk
		(415) 896-6820
February 2, 2004

Medamicus (MEDM) Name Changed to Enpath Medical, Inc. (NPTH)
Effective Today

MINNEAPOLIS, —As previously announced, Medamicus, Inc. (Nasdaq: MEDM), a leader in vascular access and stimulation lead technologies, has changed its name to Enpath Medical, Inc., effective today, Monday, February 2, 2004.  The company’s new Nasdaq ticker symbol, NPTH was effective with the opening of the stock market this morning.

The Company also announced that its web site address has changed to www.enpathmed.com.

The name Enpath reflects the company’s mission ‘to create pathways that enable the delivery of essential medical therapies’.

Enpath Medical, Inc., formerly Medamicus, Inc., headquartered in Plymouth, Minnesota, is a leader in the development and commercialization of vascular access devices and stimulation lead technologies that enable the delivery of pharmaceutical and device therapies to treat cardiac and neurological diseases, cancer and a variety of other medical conditions.